Literature DB >> 7574929

Restoration of CD44H expression in colon carcinomas reduces tumorigenicity.

K K Tanabe1, I Stamenkovic, M Cutler, K Takahashi.   

Abstract

OBJECTIVE: The functional consequences of reintroduction of the CD44H cell adhesion molecule into colon carcinomas were investigated.
BACKGROUND: CD44 is a cell surface adhesion molecule that is normally present in numerous isoforms as a result of messenger RNA alternative splicing. Individual CD44 isoforms differ in their ability to enhance tumorigenic or metastatic potential when overexpressed on tumor cells. Reverse transcriptase-polymerase chain reaction analysis demonstrates that CD44H is down-regulated during transformation of normal colon mucosa to carcinoma. The functional consequences of CD44H down-regulation in colon carcinomas has not been clarified.
METHODS: Tumor cell lines and fresh tissue specimens were examined for CD44 expression by Western blot analysis. CD44H cDNA and site-directed mutants of CD44H cDNA were transfected into colon carcinoma cells. Stable transfectants were examined for adhesion to hyaluronate, in vitro growth, and in vivo growth.
RESULTS: CD44H expression was nearly undetectable in primary colon carcinomas and colon carcinoma cell lines. In contrast, normal mucosa expressed high levels of CD44H. When CD44H was reintroduced into colon carcinoma cells, their in vitro and in vivo growth was significantly reduced. This CD44H-mediated growth rate reduction required an intact cytoplasmic domain.
CONCLUSIONS: Transformation of normal mucosa to colon carcinoma is associated with a down-regulation of CD44H, which consequently may enhance the growth rate and tumorigenicity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7574929      PMCID: PMC1234880          DOI: 10.1097/00000658-199510000-00007

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  51 in total

Review 1.  New perspectives in cell adhesion: RGD and integrins.

Authors:  E Ruoslahti; M D Pierschbacher
Journal:  Science       Date:  1987-10-23       Impact factor: 47.728

2.  A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man.

Authors:  S T Jalkanen; R F Bargatze; L R Herron; E C Butcher
Journal:  Eur J Immunol       Date:  1986-10       Impact factor: 5.532

3.  Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor.

Authors:  R Pytela; M D Pierschbacher; E Ruoslahti
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

4.  A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium.

Authors:  S Jalkanen; A C Steere; R I Fox; E C Butcher
Journal:  Science       Date:  1986-08-01       Impact factor: 47.728

Review 5.  The immunoglobulin superfamily--domains for cell surface recognition.

Authors:  A F Williams; A N Barclay
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

6.  Selective inhibition of fibronectin-mediated cell adhesion by monoclonal antibodies to a cell-surface glycoprotein.

Authors:  P J Brown; R L Juliano
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

7.  Role of cell shape in growth control.

Authors:  J Folkman; A Moscona
Journal:  Nature       Date:  1978-06-01       Impact factor: 49.962

8.  The complex CD44 transcriptional unit; alternative splicing of three internal exons generates the epithelial form of CD44.

Authors:  D L Cooper; G Dougherty; H J Harn; S Jackson; E W Baptist; J Byers; A Datta; G Phillips; N R Isola
Journal:  Biochem Biophys Res Commun       Date:  1992-01-31       Impact factor: 3.575

9.  Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors.

Authors:  S Nagasaka; K K Tanabe; J M Bruner; H Saya; R E Sawaya; R S Morrison
Journal:  J Neurosurg       Date:  1995-05       Impact factor: 5.115

10.  Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells.

Authors:  S Jalkanen; R F Bargatze; J de los Toyos; E C Butcher
Journal:  J Cell Biol       Date:  1987-08       Impact factor: 10.539

View more
  5 in total

Review 1.  CD44 and the adhesion of neoplastic cells.

Authors:  Z Rudzki; S Jothy
Journal:  Mol Pathol       Date:  1997-04

2.  Visualization of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas: non-overlapping membrane expression in cell populations positive for both markers.

Authors:  Heike Immervoll; Dag Hoem; Ole Johnny Steffensen; Hrvoje Miletic; Anders Molven
Journal:  J Histochem Cytochem       Date:  2011-04       Impact factor: 2.479

3.  Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma.

Authors:  J M Karjalainen; R H Tammi; M I Tammi; M J Eskelinen; U M Agren; J J Parkkinen; E M Alhava; V M Kosma
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

4.  Up-regulation of stem cell markers by P21-activated kinase 1 contributes to 5-fluorouracil resistance of colorectal cancer.

Authors:  Nhi Huynh; Arthur Shulkes; Graham Baldwin; Hong He
Journal:  Cancer Biol Ther       Date:  2016-06-03       Impact factor: 4.742

Review 5.  Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions.

Authors:  Saleh Ramezani; Arianna Parkhideh; Pratip K Bhattacharya; Mary C Farach-Carson; Daniel A Harrington
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.